Overall, these findings suggest that TREM2-positive microglial clustering in the Aβ plaque-bearing regions may be involved in limiting β-sheet-rich Aβ plaques in the TfRMAb-TNFR-treated 3xTg-AD mice. The gene discussed is TNFRSF1A; the disease is Alzheimer disease.